Healthcare provider profile · identity verified

Alan Michael Young, M.D.

Family Practice · WYOMING, MI · NPI 1083935894

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	561	166
Lisinopril	Lisinopril	319	98
Levothyroxine Sodium	Levothyroxine Sodium	296	83
Omeprazole	Omeprazole	273	82
Amlodipine Besylate	Amlodipine Besylate	269	85
Metformin Hcl	Metformin Hcl	155	44
Gabapentin	Gabapentin	150	34
Simvastatin	Simvastatin	143	44
Eliquis	Apixaban	136	28
Hydrochlorothiazide	Hydrochlorothiazide	136	46
Losartan Potassium	Losartan Potassium	119	40
Trazodone Hcl	Trazodone Hcl	106	35
Metoprolol Succinate	Metoprolol Succinate	104	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	26
Duloxetine Hcl	Duloxetine Hcl	96	21
Sertraline Hcl	Sertraline Hcl	88	24
Tamsulosin Hcl	Tamsulosin Hcl	87	31
Rosuvastatin Calcium	Rosuvastatin Calcium	80	25
Furosemide	Furosemide	79	28
Trulicity	Dulaglutide	73	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	70	27
Pravastatin Sodium	Pravastatin Sodium	68	23
Metformin Hcl Er	Metformin Hcl	67	20
Olmesartan Medoxomil	Olmesartan Medoxomil	67	17
Chlorthalidone	Chlorthalidone	65	19
Meloxicam	Meloxicam	65	23
Pantoprazole Sodium	Pantoprazole Sodium	64	23
Tramadol Hcl	Tramadol Hcl	63	13
Fluticasone Propionate	Fluticasone Propionate	59	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	16
Montelukast Sodium	Montelukast Sodium	56	17
Potassium Chloride	Potassium Chloride	55	13
Venlafaxine Hcl Er	Venlafaxine Hcl	52	14
Atenolol	Atenolol	49	15
Hydroxyzine Hcl	Hydroxyzine Hcl	49	15
Citalopram Hbr	Citalopram Hydrobromide	47	14
Carvedilol	Carvedilol	45	15
Escitalopram Oxalate	Escitalopram Oxalate	45	17
Buspirone Hcl	Buspirone Hcl	43	13
Finasteride	Finasteride	39	14
Alendronate Sodium	Alendronate Sodium	38	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	12
Pregabalin	Pregabalin	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	11
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Clonazepam	Clonazepam	34	suppressed
Xarelto	Rivaroxaban	34	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	33	11
Bupropion Xl	Bupropion Hcl	32	suppressed
Jardiance	Empagliflozin	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	11
Spironolactone	Spironolactone	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Allopurinol	Allopurinol	24	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Glipizide	Glipizide	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Prednisone	Prednisone	21	11
Benazepril Hcl	Benazepril Hcl	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Varenicline Tartrate	Varenicline Tartrate	19	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Ozempic	Semaglutide	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Jantoven	Warfarin Sodium	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Alprazolam	Alprazolam	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Torsemide	Torsemide	14	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Famotidine	Famotidine	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Clopidogrel	Clopidogrel Bisulfate	12	suppressed
Estradiol	Estradiol	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Baclofen	Baclofen	11	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error